Does base deficit predict mortality in @entity1 with severe XXXX ?

@entity1 @entity131 @entity772 @entity51 @entity519 @entity1230 @entity130
OBJECTIVE: @entity51 ( @entity51 ) is a marker of tissue @entity519 in @entity1230 @entity1 . It guides resuscitative measures, and predicts outcomes, complications and mortality. The aim of this study was to examine the presence of @entity51 in @entity1 with isolated severe @entity131 ( @entity131 ), and to assess if it correlates with the outcomes in these @entity1 . METHOD: This was a retrospective observational study. All @entity1 over the age of 16 years presenting to Aga Khan University Hospital from 2009 to 2013 with @entity131 , were included. Data was extracted from 2009 to 2013. Glasgow Outcome Scale (GOS) of 4 and 5 at last follow up was categorized as favorable outcome. Data was analyzed using SPSS version 19 and receiver operative curve (ROC) was generated for @entity51 as a predictor of mortality and unfavorable outcome. RESULTS: One hundred and eight @entity1 were analyzed. Ninety-eight (90.7%) were males. Mean age was 36.69      17.65. Eighty-eight (81.5%) @entity1 had @entity51 , while 20 (18.5%) @entity1 had base excess. 62 (58.5%) of the @entity1 had unfavorable outcomes. @entity51 on admission had a statistically significant negative correlation with Glasgow @entity772 Scale (GCS) on presentation (r  =  -0.239, p  =  0.025) and Revised @entity130 Score (RTS) (r  =  -0.214, p  =  0.046). However, there was no statistically significant difference in means of @entity51 between survivors and non survivors. Area under receiver operator curve (ROC) for @entity51 as a predictor of mortality statistically non-significant. CONCLUSION: Although @entity51 is correlated with GCS at presentation and RTS, it is not a reliable prognostic marker for outcome and mortality in @entity1 with @entity131 .
